Abstract
We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1053-1055 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 67 |
| Issue number | 6 |
| DOIs | |
| State | Published - Sep 1 2006 |
| Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint Dive into the research topics of 'Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa'. Together they form a unique fingerprint.
Cite this
Sugg, R. M., Gonzales, N. R., Matherne, D. E., Ribo, M., Shaltoni, H., Baraniuk, S., Noser, E. A., & Grotta, J. C. (2006). Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology, 67(6), 1053-1055. https://doi.org/10.1212/01.wnl.0000239154.51331.c4